André C, Légeron P
Unité de Thérapie Comportementale et Cognitive, Service Hospitalo-Universitaire, Centre Hospitalier Sainte-Anne, Paris.
Encephale. 1995 Jan-Feb;21(1):1-13.
Although social phobia is a real pathological condition, it has often been neglected. In fact, social phobia is among the least studies of the major anxiety disorders. This is quite surprising, as approximately 2% of the population suffer from debilitating social phobia with devastating effects on career and quality of life, and as this disorder can now be considered as a treatable condition. After defining social phobia, the authors will describe the prevalence, clinical features and etiology of social phobia. Effective psychopharmacological and psychological treatments of social phobia will also be reviewed. The drugs that have been most studied are monoamine oxidase inhibitors and beta-blockers. Several controlled studies have also concluded that behavioral and cognitive therapies (exposure in vivo therapy, social skills training, cognitive restructuring) are beneficial for social phobics. The combination of psychopharmacotherapy and psychological interventions also seems promising. Finally, as it is necessary to distinguish among various subtypes of social phobia, further studies will have to investigate whether specific subtypes do better or worse with specific treatments.
尽管社交恐惧症是一种真实的病理状况,但它常常被忽视。事实上,社交恐惧症是主要焦虑症中研究最少的病症之一。这相当令人惊讶,因为约2%的人口患有使人衰弱的社交恐惧症,对职业和生活质量产生毁灭性影响,而且现在这种病症可被视为一种可治疗的疾病。在定义社交恐惧症之后,作者将描述社交恐惧症的患病率、临床特征和病因。还将综述社交恐惧症有效的心理药物治疗和心理治疗方法。研究最多的药物是单胺氧化酶抑制剂和β受体阻滞剂。几项对照研究也得出结论,行为和认知疗法(现场暴露疗法、社交技能训练、认知重构)对社交恐惧症患者有益。心理药物治疗和心理干预相结合似乎也很有前景。最后,由于有必要区分社交恐惧症的各种亚型,进一步的研究将不得不调查特定亚型接受特定治疗的效果是更好还是更差。